Literature DB >> 26872090

Comparative Assessment of Female Mouse Model of Graves' Orbitopathy Under Different Environments, Accompanied by Proinflammatory Cytokine and T-Cell Responses to Thyrotropin Hormone Receptor Antigen.

Utta Berchner-Pfannschmidt1, Sajad Moshkelgosha1, Salvador Diaz-Cano1, Bärbel Edelmann1, Gina-Eva Görtz1, Mareike Horstmann1, Alistair Noble1, Wiebke Hansen1, Anja Eckstein1, J Paul Banga1.   

Abstract

We recently described a preclinical model of Graves' orbitopathy (GO), induced by genetic immunization of eukaryotic expression plasmid encoding human TSH receptor (TSHR) A-subunit by muscle electroporation in female BALB/c mice. The onset of orbital pathology is characterized by muscle inflammation, adipogenesis, and fibrosis. Animal models of autoimmunity are influenced by their environmental exposures. This follow-up study was undertaken to investigate the development of experimental GO in 2 different locations, run in parallel under comparable housing conditions. Functional antibodies to TSHR were induced in TSHR A-subunit plasmid-immunized animals, and antibodies to IGF-1 receptor α-subunit were also present, whereas control animals were negative in both locations. Splenic T cells from TSHR A-subunit primed animals undergoing GO in both locations showed proliferative responses to purified TSHR antigen and secreted interferon-γ, IL-10, IL-6, and TNF-α cytokines. Histopathological evaluation showed orbital tissue damage in mice undergoing GO, manifest by adipogenesis, fibrosis, and muscle damage with classic signs of myopathy. Although no inflammatory infiltrate was observed in orbital tissue in either location, the appearances were consistent with a "hit-and-run" immune-mediated inflammatory event. A statistically significant increase of cumulative incidence of orbital pathology when compared with control animals was shown for both locations, confirming onset of orbital dysimmune myopathy. Our findings confirm expansion of the model in different environments, accompanied with increased prevalence of T cell-derived proinflammatory cytokines, with relevance for pathogenesis. Wider availability of the model makes it suitable for mechanistic studies into pathogenesis and undertaking of novel therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26872090     DOI: 10.1210/en.2015-1829

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  19 in total

Review 1.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

Review 2.  The thyroid, the eyes and the gut: a possible connection.

Authors:  D Covelli; M Ludgate
Journal:  J Endocrinol Invest       Date:  2017-01-07       Impact factor: 4.256

3.  Editorial: Mechanisms and Novel Therapies in Graves' Orbitopathy: Current Update.

Authors:  Huifang Zhou; Ilaria Muller; Kelvin Kam-Lung Chong; Marian Ludgate; Sijie Fang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-29       Impact factor: 6.055

4.  Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.

Authors:  A Schlüter; M Horstmann; S Diaz-Cano; S Plöhn; K Stähr; S Mattheis; M Oeverhaus; S Lang; U Flögel; U Berchner-Pfannschmidt; A Eckstein; J P Banga
Journal:  Clin Exp Immunol       Date:  2017-11-17       Impact factor: 4.330

5.  Microbiome and Graves' Orbitopathy.

Authors:  Giulia Masetti; Marian Ludgate
Journal:  Eur Thyroid J       Date:  2020-11-05

6.  PRL-1 overexpressed placenta-derived mesenchymal stem cells suppress adipogenesis in Graves' ophthalmopathy through SREBP2/HMGCR pathway.

Authors:  Mira Park; Jae Yeon Kim; Jun Mo Kang; Hey Jin Lee; Jasvinder Paul Banga; Gi Jin Kim; Helen Lew
Journal:  Stem Cell Res Ther       Date:  2021-05-29       Impact factor: 6.832

Review 7.  Building the Case for Insulin-Like Growth Factor Receptor-I Involvement in Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Front Endocrinol (Lausanne)       Date:  2017-01-03       Impact factor: 5.555

Review 8.  New insights into the pathogenesis and nonsurgical management of Graves orbitopathy.

Authors:  Peter N Taylor; Lei Zhang; George J Kahaly; Marian Ludgate; Richard W J Lee; Ilaria Muller; Daniel G Ezra; Colin M Dayan
Journal:  Nat Rev Endocrinol       Date:  2019-12-30       Impact factor: 43.330

9.  Noninflammatory Diffuse Follicular Hypertrophy/Hyperplasia of Graves Disease: Morphometric Evaluation in an Experimental Mouse Model.

Authors:  Anke Schlüter; Anja K Eckstein; Alexandra Brenzel; Mareike Horstmann; Stephan Lang; Utta Berchner-Pfannschmidt; J Paul Banga; Salvador Diaz-Cano
Journal:  Eur Thyroid J       Date:  2018-04-13

Review 10.  New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor.

Authors:  Terry J Smith
Journal:  F1000Res       Date:  2018-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.